Isolyte H and 5 % Dextrose (lvp solution with potassium) Disease Interactions
There are 2 disease interactions with Isolyte H and 5 % Dextrose (lvp solution with potassium):
Sodium salts (applies to Isolyte H and 5 % Dextrose) sodium/water imbalance
Major Potential Hazard, Moderate plausibility. Applicable conditions: Fluid Retention, Congestive Heart Failure
Sodium chloride can induce sodium and water retention and result in hypernatremia, hypokalemia, edema and aggravation of congestive heart failure. Therapy with sodium- containing agents should be administered with extreme caution, if at all, in patients with congestive heart failure, severe renal insufficiency, and in clinical states where there is edema with sodium retention. Clinical monitoring of acid/base balance and electrolytes prior to, during, a following completion of therapy with sodium- containing agents is recommended.
- "Product Information. Megace (megestrol)." Bristol-Myers Squibb, Princeton, NJ.
- "Product Information. Calcibind (cellulose sodium phosphate)." Mission Pharmaceutical Company, San Antonio, TX.
- "Product Information. Sodium Benzoate (sodium benzoate)." Taylor Pharmaceuticals, San Clemente, CA.
LVP solution with potassium (applies to Isolyte H and 5 % Dextrose) hyperkalemia
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Renal Dysfunction
Solutions containing potassium ions should be used with great care, if at all, in patients with hyperkalemia, severe renal failure, and in conditions in which potassium retention is present.
Isolyte H and 5 % Dextrose (lvp solution with potassium) drug interactions
There are 62 drug interactions with Isolyte H and 5 % Dextrose (lvp solution with potassium)
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.